Literature DB >> 17176916

Restless legs syndrome in hemodialysis patients: health-related quality of life and laboratory data analysis.

A Kawauchi1, Y Inoue, T Hashimoto, N Tachibana, S Shirakawa, Y Mizutani, T Ono, T Miki.   

Abstract

AIMS: To compare clinical data, sleep quality and health-related quality of life (HRQOL) with and without RLS in HD patients.
MATERIALS AND METHODS: The international RLS study group diagnosis questionnaire was completed by 228 HD patients. The Pittsburg Sleep Quality Index (PSQI) for the evaluation of sleep quality and the Kidney Disease Quality of Life (KDQOL-SF) for the analysis of HRQOL were also used.
RESULTS: 53 (23%) patients were diagnosed as RLS. Age and age at the initiation of HD were significantly younger in the RLS group. Serum calcium concentration (Ca) was significantly higher in the RLS group. Sleep quality evaluated by PSQI was significantly lower in the RLS group. In SF-36 domains of KDQOL-SF, bodily pain, general health perceptions, vitality, role functioning emotional, mental health and mental component score were significantly lower in the RLS group. In kidney targeted scales of KDQOL-SF, symptoms/problems, burden of kidney disease, cognitive function, quality of social interaction, sleep and patient satisfaction were significantly lower in the RLS group.
CONCLUSION: High Ca was possibly connected to the pathophysiology of RLS which impaired sleep quality as well as HRQOL including mental health and many kidney disease related scales.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17176916     DOI: 10.5414/cnp66440

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  20 in total

Review 1.  Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment.

Authors:  Paul Yeh; Arthur S Walters; John W Tsuang
Journal:  Sleep Breath       Date:  2011-10-26       Impact factor: 2.816

2.  Restless legs syndrome: a unique case and essentials of diagnosis and treatment.

Authors:  Pinky Agarwal; Alida Griffith
Journal:  Medscape J Med       Date:  2008-12-31

3.  Racial differences in restless legs symptoms and serum ferritin in an incident dialysis patient cohort.

Authors:  Nancy G Kutner; Rebecca Zhang; Yijian Huang; Donald L Bliwise
Journal:  Int Urol Nephrol       Date:  2012-01-05       Impact factor: 2.370

Review 4.  Sleep-related movement disorders.

Authors:  Giovanni Merlino; Gian Luigi Gigli
Journal:  Neurol Sci       Date:  2011-12-28       Impact factor: 3.307

Review 5.  Sleep disorders and chronic kidney disease.

Authors:  Stephanie C Maung; Ammar El Sara; Cherylle Chapman; Danielle Cohen; Daniel Cukor
Journal:  World J Nephrol       Date:  2016-05-06

6.  The influence of parathyroidectomy on restless legs syndrome in patients with renal hyperparathyroidism.

Authors:  Ralph Schneider; Elias Karakas; Detlef K Bartsch; Katja Schlosser
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

7.  Prevalence of Restless Legs Syndrome in Patients with Inflammatory Bowel Disease.

Authors:  Ikuko Takahara; Fuminao Takeshima; Tatsuki Ichikawa; Toshihisa Matsuzaki; Hidetaka Shibata; Satoshi Miuma; Yuko Akazawa; Hisamitsu Miyaaki; Naota Taura; Kazuhiko Nakao
Journal:  Dig Dis Sci       Date:  2016-12-29       Impact factor: 3.199

8.  Sleep disruption in patients with sleep apnea and end-stage renal disease.

Authors:  Andrea Loewen; AnDrea Siemens; Patrick Hanly
Journal:  J Clin Sleep Med       Date:  2009-08-15       Impact factor: 4.062

9.  Measurement invariance of the kidney disease and quality of life instrument (KDQOL-SF) across veterans and non-veterans.

Authors:  Karen L Saban; Fred B Bryant; Domenic J Reda; Kevin T Stroupe; Denise M Hynes
Journal:  Health Qual Life Outcomes       Date:  2010-10-25       Impact factor: 3.186

10.  Comparison of health-related quality of life measures for chronic renal failure: quality of well-being scale, short-form-6D, and the kidney disease quality of life instrument.

Authors:  Karen L Saban; Kevin T Stroupe; Fred B Bryant; Domenic J Reda; Margaret M Browning; Denise M Hynes
Journal:  Qual Life Res       Date:  2008-09-13       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.